ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹1,641 Cr | ₹1,831 Cr | ₹1,533 Cr | ₹1,752 Cr | ₹1,664 Cr |
What is the latest Total Current Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹1,641 Cr |
Mar2022 | ₹1,831 Cr |
Mar2021 | ₹1,533 Cr |
Mar2020 | ₹1,752 Cr |
Mar2019 | ₹1,664 Cr |
How is Total Current Liabilities of ALEMBIC PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹1,641 Cr | -10.37 | |
Mar2022 | ₹1,831 Cr | 19.39 | |
Mar2021 | ₹1,533 Cr | -12.47 | |
Mar2020 | ₹1,752 Cr | 5.29 | |
Mar2019 | ₹1,664 Cr | - |
Compare Total Current Liabilities of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹19,605.9 Cr | 6.2% | 3.6% | 83.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,987.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | 6.2% |
3.6% |
83.1% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses